These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17176847)

  • 41. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Esophageal varices in rat models of liver cirrhosis.
    Nishida R; Inoue R; Takimoto Y; Kita T
    Dig Dis Sci; 1998 Jun; 43(6):1296-301. PubMed ID: 9635621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Emergency sclerotherapy in esophageal varices bleeding: prospective study in unselected patients with portal hypertension].
    Szczepanik AB; Misiak A; Meissner AJ
    Pol Merkur Lekarski; 2007 May; 22(131):354-6. PubMed ID: 17679366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Portal hypertension and variceal hemorrhage.
    Toubia N; Sanyal AJ
    Med Clin North Am; 2008 May; 92(3):551-74, viii. PubMed ID: 18387376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of endoscopic findings and ultrasonographic signals of portal hypertension].
    Sergiacomo L; Ciancaglini R; De Feudis L; Delle Monache G; Orlando D; Bronzi G; Pesa O
    Ann Ital Med Int; 1986 Sep; 1(3):225-8. PubMed ID: 3079366
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cirrhosis of the liver and the portal circulation].
    Ziegan J; Massmann J
    Virchows Arch Pathol Anat Physiol Klin Med; 1967; 344(4):322-30. PubMed ID: 5304290
    [No Abstract]   [Full Text] [Related]  

  • 47. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia.
    El-Husseini R; Kaplan MM
    Am J Gastroenterol; 2004 Sep; 99(9):1859-60. PubMed ID: 15330929
    [No Abstract]   [Full Text] [Related]  

  • 48. Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding.
    Fortune BE; Jackson J; Leonard J; Trotter JF
    Expert Opin Pharmacother; 2009 Oct; 10(14):2337-42. PubMed ID: 19708854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective periesophagogastric devascularization in portal hypertension: results of 56 patients.
    Shi B; Yang Z; Wang X; Xu J; Lu X; Liang F; Mu Q; Wu TH
    Hepatogastroenterology; 2009; 56(90):492-7. PubMed ID: 19579627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional status of beta-2-adrenoceptor in isolated membranes of mature erythrocytes from patients with cirrhosis and oesophageal varices.
    Hernández FT; Zapater P; De-Madaria E; Palazón JM; Pascual S; Irurzun J; Such J; Perez-Mateo M; Horga JF
    Vascul Pharmacol; 2006 Jun; 44(6):464-8. PubMed ID: 16624626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
    Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computerized endoscopic balloon manometry to detect esophageal variceal pressure.
    Kong DR; Xu JM; Zhang L; Zhang C; Fu ZQ; He BB; Sun B; Xie Y
    Endoscopy; 2009 May; 41(5):415-20. PubMed ID: 19418395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.
    Fong TV; Hung FC; Chiu KW; Chiu YC; Wu KL; Kuo CH; Kuo CM
    Hepatogastroenterology; 2008; 55(84):1055-8. PubMed ID: 18705327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of an isolated gastric variceal bleed secondary to a pancreatic neuroendocrine tumour.
    Daveson J; Masson J; Cameron D; Jennings M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1144-8. PubMed ID: 17998842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma?
    Kadouchi K; Higuchi K; Shiba M; Okazaki H; Yamamori K; Sasaki E; Tominaga K; Watanabe T; Fujiwara Y; Oshitani N; Arakawa T
    J Gastroenterol Hepatol; 2007 Feb; 22(2):240-6. PubMed ID: 17295878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstructive jaundice due to ductus hepaticus communis cyst in patient with liver cirrhosis.
    Mulyana E; Syam AF
    Acta Med Indones; 2011 Oct; 43(4):260-1. PubMed ID: 22156359
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
    Bolondi L; Piscaglia F; Gatta A; Salerno F; Bernardi M; Ascione A; Ferraù O; Sacerdoti D; Visentin S; Trevisani F; Mazzanti R; Donati G; Arena U; Gentilini P;
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1395-402. PubMed ID: 16931172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The changing filling of esophageal varices].
    Burgmann W
    Med Welt; 1965 Jul; 27():1507-12. PubMed ID: 5889704
    [No Abstract]   [Full Text] [Related]  

  • 60. [Portal hypertension in localized hepatocellular carcinoma without cirrhosis].
    Streifler I; Dux S; Pitlik S
    Harefuah; 1982 Jan; 102(2):64-5. PubMed ID: 6284600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.